1276113-31-5 Usage
General Description
1,6-Dimethylindazol-3-amine is a chemical compound with the molecular formula C11H12N2. It is an indazole derivative, which is a class of nitrogen-containing heterocyclic compounds. This chemical is commonly used in the pharmaceutical industry as a building block for the synthesis of various pharmaceutical and medicinal compounds. It has also been studied for its potential biological activities, including its possible role as an anticancer agent. The chemical structure of 1,6-dimethylindazol-3-amine makes it a valuable intermediate for the preparation of diverse and complex molecules in drug discovery and development. Overall, 1,6-dimethylindazol-3-amine is an important and versatile compound with potential applications in both research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1276113-31-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,6,1,1 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1276113-31:
(9*1)+(8*2)+(7*7)+(6*6)+(5*1)+(4*1)+(3*3)+(2*3)+(1*1)=135
135 % 10 = 5
So 1276113-31-5 is a valid CAS Registry Number.
1276113-31-5Relevant articles and documents
A general, one-step synthesis of substituted indazoles using a flow reactor
Wheeler, Rob C.,Baxter, Emma,Campbell, Ian B.,MacDonald, Simon J. F.
experimental part, p. 565 - 569 (2011/12/02)
Flow chemistry is a rapidly emerging technology within the pharmaceutical industry, both within medicinal and development chemistry groups. The advantages of flow chemistry, increased safety, improved reproducibility, enhanced scalability, are readily apparent, and we aimed to exploit this technology in order to provide small amounts of pharmaceutically interesting fragments via a safe and scalable route, which would enable the rapid synthesis of multigram quantities on demand. Here we report a general and versatile route which utilises flow chemistry to deliver a range of known and novel indazoles, including 3-amino and 3-hydroxy analogues.
